SOURCE: Alpharma Inc.

January 29, 2008 10:34 ET

Alpharma to Present at Merrill Lynch & Co., Inc. Global Pharmaceutical, Biotechnology & Medical Device Conference

BRIDGEWATER, NJ--(Marketwire - January 29, 2008) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 5, 2008 at 9:20AM Eastern Standard Time. The conference will be held at The Grand Hyatt in New York City.

This presentation will be webcast live and can be accessed through Alpharma's website, www.alpharma.com, through its Investor Support and Company Calendar tabs.

An archived version will be available for 14 days through February 18, 2008 after the live presentation and can be accessed at the same location.

Alpharma press releases are also available at our website: www.alpharma.com

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch). In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Jack Howarth
    Vice President, Investor Relations
    908-566-4153
    Email Contact